Clinical Trial Update: A 5-year Superion™ IDS Clinical Outcomes Post-Approval Evaluation (SCOPE) [NA]

View source ↗

Summary

This clinical trial update reports five-year, post-approval outcomes for the Superion IDS interspinous distraction system in lumbar spinal stenosis, with the st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lumbar Spinal Stenosis

Drugs mentioned

• Superion IDS Interspinous Distraction System

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Lumbar Spinal Stenosis | NA | Status: ACTIVE_NOT_RECRUITING